Estimates Revisions Tenax Therapeutics, Inc.
Stocks
TENX
US88032L6056
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 28/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.850 USD | +2.21% |
|
-2.63% | -84.82% |
| 09-20 | Tenax Therapeutics, Inc.(NasdaqCM:TENX) added to S&P Global BMI Index | CI |
| 08-31 | Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- TENX Stock
- Consensus Tenax Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
